Theralase Technologies Inc. (TLTFF)
USD 0.13
(3.04%)
USD 0.13
(3.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -4.74 Million CAD | 11.66% |
| 2022 | -5.2 Million CAD | -15.09% |
| 2021 | -4.51 Million CAD | 19.2% |
| 2020 | -5.59 Million CAD | 24.28% |
| 2019 | -7.38 Million CAD | -120.58% |
| 2018 | -3.34 Million CAD | 44.91% |
| 2017 | -6.07 Million CAD | -223.51% |
| 2016 | 4.92 Million CAD | -5.51% |
| 2015 | 5.2 Million CAD | 102.15% |
| 2014 | 2.57 Million CAD | 133.41% |
| 2013 | 1.1 Million CAD | -26.88% |
| 2012 | 1.5 Million CAD | 203.35% |
| 2011 | -1.46 Million CAD | -221.4% |
| 2010 | 1.2 Million CAD | 397.51% |
| 2009 | 241.82 Thousand CAD | -78.24% |
| 2008 | 1.11 Million CAD | 1.53% |
| 2007 | 1.09 Million CAD | 280.14% |
| 2006 | 287.89 Thousand CAD | 2299.51% |
| 2005 | 11.99 Thousand CAD | -80.57% |
| 2004 | 61.74 Thousand CAD | 15.01% |
| 2003 | 53.68 Thousand CAD | 8.09% |
| 2002 | 49.66 Thousand CAD | -90.17% |
| 2001 | 505.17 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.46 Million CAD | -46.02% |
| 2024 Q2 | -1.13 Million CAD | 22.0% |
| 2023 Q4 | -1 Million CAD | 0.23% |
| 2023 Q1 | -1.4 Million CAD | -60.87% |
| 2023 FY | -4.59 Million CAD | 11.66% |
| 2023 Q2 | -1.16 Million CAD | 17.21% |
| 2023 Q3 | -1 Million CAD | 13.59% |
| 2022 Q4 | -871.78 Thousand CAD | 36.86% |
| 2022 Q2 | -1.24 Million CAD | 27.39% |
| 2022 Q3 | -1.38 Million CAD | -11.33% |
| 2022 Q1 | -1.7 Million CAD | -34.77% |
| 2022 FY | -5.2 Million CAD | -15.09% |
| 2021 Q2 | -1.13 Million CAD | -8.32% |
| 2021 FY | -4.51 Million CAD | 19.2% |
| 2021 Q4 | -1.26 Million CAD | -18.29% |
| 2021 Q3 | -1.07 Million CAD | 5.48% |
| 2021 Q1 | -1.04 Million CAD | -18.34% |
| 2020 FY | -5.59 Million CAD | 24.28% |
| 2020 Q3 | -1.44 Million CAD | 11.06% |
| 2020 Q2 | -1.62 Million CAD | 1.22% |
| 2020 Q1 | -1.64 Million CAD | 45.34% |
| 2020 Q4 | -884.31 Thousand CAD | 38.72% |
| 2019 Q1 | -1.11 Million CAD | -51.43% |
| 2019 Q2 | -1.48 Million CAD | -32.44% |
| 2019 Q3 | -1.78 Million CAD | -20.35% |
| 2019 Q4 | -3 Million CAD | -68.59% |
| 2019 FY | -7.38 Million CAD | -120.58% |
| 2018 Q2 | -887.22 Thousand CAD | 11.16% |
| 2018 FY | -3.34 Million CAD | 44.91% |
| 2018 Q4 | -738.65 Thousand CAD | -2.01% |
| 2018 Q1 | -998.65 Thousand CAD | 16.98% |
| 2018 Q3 | -724.07 Thousand CAD | 18.39% |
| 2017 Q4 | -1.2 Million CAD | -172.65% |
| 2017 Q3 | 1.65 Million CAD | -6.23% |
| 2017 FY | -6.07 Million CAD | -223.51% |
| 2017 Q1 | 1.47 Million CAD | 46.79% |
| 2017 Q2 | 1.76 Million CAD | 19.95% |
| 2016 Q2 | 1.24 Million CAD | 8.61% |
| 2016 Q4 | 1 Million CAD | -31.4% |
| 2016 Q3 | 1.46 Million CAD | 17.48% |
| 2016 FY | 4.92 Million CAD | -5.51% |
| 2016 Q1 | 1.14 Million CAD | 19.96% |
| 2015 Q2 | 1.34 Million CAD | 44.11% |
| 2015 FY | 5.2 Million CAD | 102.15% |
| 2015 Q1 | 933.64 Thousand CAD | 11.18% |
| 2015 Q4 | 955.06 Thousand CAD | -51.62% |
| 2015 Q3 | 1.97 Million CAD | 46.71% |
| 2014 Q3 | -1.05 Million CAD | -393.96% |
| 2014 Q2 | 358.93 Thousand CAD | 11.88% |
| 2014 Q1 | 320.81 Thousand CAD | -36.72% |
| 2014 FY | 2.57 Million CAD | 133.41% |
| 2014 Q4 | 839.76 Thousand CAD | 179.59% |
| 2013 FY | 1.1 Million CAD | -26.88% |
| 2013 Q4 | 506.97 Thousand CAD | 172.87% |
| 2013 Q3 | 185.79 Thousand CAD | 170.45% |
| 2013 Q2 | 68.69 Thousand CAD | -79.33% |
| 2013 Q1 | 332.43 Thousand CAD | -36.59% |
| 2012 Q4 | 524.27 Thousand CAD | 51.42% |
| 2012 Q1 | -450.67 Thousand CAD | -99.61% |
| 2012 Q2 | 195.35 Thousand CAD | 143.35% |
| 2012 FY | 1.5 Million CAD | 203.35% |
| 2012 Q3 | 346.23 Thousand CAD | 77.23% |
| 2011 Q4 | -225.78 Thousand CAD | -153.01% |
| 2011 Q1 | 449.08 Thousand CAD | 38.71% |
| 2011 Q2 | 359.8 Thousand CAD | -19.88% |
| 2011 Q3 | 425.94 Thousand CAD | 18.38% |
| 2011 FY | -1.46 Million CAD | -221.4% |
| 2010 Q2 | 199.24 Thousand CAD | -28.13% |
| 2010 Q4 | 323.76 Thousand CAD | -19.64% |
| 2010 FY | 1.2 Million CAD | 397.51% |
| 2010 Q1 | 277.24 Thousand CAD | 413.39% |
| 2010 Q3 | 402.86 Thousand CAD | 102.19% |
| 2009 Q4 | -88.46 Thousand CAD | -200.68% |
| 2009 Q1 | 216.25 Thousand CAD | -29.14% |
| 2009 Q2 | 26.16 Thousand CAD | -87.9% |
| 2009 Q3 | 87.87 Thousand CAD | 235.84% |
| 2009 FY | 241.82 Thousand CAD | -78.24% |
| 2008 Q4 | 305.17 Thousand CAD | 28.15% |
| 2008 Q1 | 346.93 Thousand CAD | -52.51% |
| 2008 Q2 | 220.93 Thousand CAD | -36.32% |
| 2008 Q3 | 238.13 Thousand CAD | 7.78% |
| 2008 FY | 1.11 Million CAD | 1.53% |
| 2007 Q2 | 92.53 Thousand CAD | 221.47% |
| 2007 FY | 1.09 Million CAD | 280.14% |
| 2007 Q3 | 195.21 Thousand CAD | 110.96% |
| 2007 Q4 | 730.47 Thousand CAD | 274.2% |
| 2007 Q1 | -76.17 Thousand CAD | -148.71% |
| 2006 Q2 | 54.26 Thousand CAD | -26.65% |
| 2006 FY | 287.89 Thousand CAD | 2299.51% |
| 2006 Q3 | 3276.00 CAD | -93.96% |
| 2006 Q4 | 156.37 Thousand CAD | 4673.38% |
| 2006 Q1 | 73.97 Thousand CAD | 553.98% |
| 2005 Q2 | 40.54 Thousand CAD | 459.79% |
| 2005 FY | 11.99 Thousand CAD | -80.57% |
| 2005 Q4 | -16.29 Thousand CAD | -225.57% |
| 2005 Q1 | 7242.00 CAD | 294.83% |
| 2005 Q3 | -5005.00 CAD | -112.35% |
| 2004 FY | 61.74 Thousand CAD | 15.01% |
| 2004 Q3 | -16.09 Thousand CAD | -133.98% |
| 2004 Q4 | -3717.00 CAD | 76.91% |
| 2004 Q2 | 47.38 Thousand CAD | 2206.77% |
| 2004 Q1 | 2054.00 CAD | -85.49% |
| 2003 Q2 | -10.66 Thousand CAD | 11.78% |
| 2003 Q1 | -12.08 Thousand CAD | -204.17% |
| 2003 Q3 | 16.07 Thousand CAD | 250.75% |
| 2003 FY | 53.68 Thousand CAD | 8.09% |
| 2003 Q4 | 14.15 Thousand CAD | -11.97% |
| 2002 Q2 | 11.44 Thousand CAD | -2.98% |
| 2002 Q4 | 11.6 Thousand CAD | -27.28% |
| 2002 Q3 | 15.95 Thousand CAD | 39.43% |
| 2002 FY | 49.66 Thousand CAD | -90.17% |
| 2002 Q1 | 11.79 Thousand CAD | 0.0% |
| 2001 FY | 505.17 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | -703 Thousand USD | -575.244% |
| SS Innovations International, Inc. | -20.66 Million USD | 77.033% |
| Össur hf. | 87.46 Million USD | 105.428% |
| Össur hf. | 87.46 Million USD | 105.428% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| QHSLab, Inc. | -240.15 Thousand USD | -1876.601% |
| BrainsWay Ltd. | -4.92 Million USD | 3.654% |
| BioElectronics Corporation | -274.29 Thousand USD | -1630.637% |
| AVITA Medical, Inc. | -40.4 Million USD | 88.251% |
| Zecotek Photonics Inc. | -3.65 Million USD | -29.813% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| Wellstar International, Inc. | -1.79 Million USD | -164.5% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 1807.56% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 328.11% |
| Escalon Medical Corp. | -104.47 Thousand USD | -4443.594% |
| Aurora Spine Corporation | -446.19 Thousand USD | -963.874% |
| NewCardio, Inc. | -9.45 Million USD | 49.817% |
| Avitar, Inc. | 2.73 Million USD | 273.703% |
| Vivos Inc. | -2.79 Million USD | -69.95% |
| Theraclion SA | -3.48 Million USD | -36.372% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -1884.799% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -167.942% |
| Positron Corporation | -1.36 Million USD | -248.849% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -1152.808% |
| Nanomix Corporation | -8.43 Million USD | 43.737% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -571.397% |
| Stratec SE | 25.26 Million USD | 118.786% |
| Heart Tronics, Inc. | 14.46 Million USD | 132.828% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -3838.54% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -129.884% |
| Lombard Medical, Inc. | -29.33 Million USD | 83.818% |
| ALR Technologies Inc. | -2.94 Million USD | -61.115% |
| MicroPort Scientific Corporation | -516.16 Million USD | 99.08% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 11911.015% |
| VMS Rehab Systems, Inc. | -68.66 USD | -6913627.061% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 77.101% |
| Guided Therapeutics, Inc. | -3.45 Million USD | -37.315% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -779.068% |
| Ingen Technologies, Inc. | -1.61 Million USD | -194.177% |
| United American Healthcare Corporation | -67 Thousand USD | -6985.022% |
| Odyssey Group International, Inc. | 14.26 Million USD | 133.286% |
| IR-Med Inc. | -4.91 Million USD | 3.34% |
| Polarean Imaging plc | -12.55 Million USD | 62.194% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -1064.957% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -647.921% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -689.16% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 1183.337% |
| Urologix, Inc. | -6.93 Million USD | 31.501% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -275.749% |
| Nexeon MedSystems Inc. | -6.26 Million USD | 24.23% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -1961.737% |
| Smith & Nephew plc | 425 Million USD | 101.117% |
| NIOX Group Plc | 4.6 Million USD | 203.195% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 1336.769% |
| Broncus Holding Corporation | -33.22 Million USD | 85.711% |
| Brain Scientific Inc. | -9.6 Million USD | 50.596% |
| Pressure BioSciences, Inc. | -9.5 Million USD | 50.05% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -7720.5% |